Related Experiment Video
Updated: Aug 23, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Systemic Inflammation Is Associated with Pulmonary Hypertension in Isolated Giant Omphalocele: A Population-Based
Baptiste Teillet1, Mohamed Riadh Boukhris1,2, Rony Sfeir2,3
1Department of Neonatology, Pôle Femme-Mère-Nouveau-Né, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, F-59000 Lille, France.
Insights
A prolonged inflammatory state, marked by elevated CRP, platelets, and white blood cells, is linked to pulmonary hypertension (PH) in infants with giant omphaloceles (GO) undergoing delayed closure. This finding offers insights into PH development in this patient group.
Area of Science:
- Pediatric Surgery
- Neonatology
- Cardiology
Background:
- Giant omphalocele (GO) is a complex congenital anomaly requiring specialized management.
- Pulmonary hypertension (PH) is a serious complication in neonates, particularly those with congenital defects.
- The relationship between perinatal factors and PH development in isolated GO is not well understood.
Purpose of the Study:
- To identify perinatal factors associated with the development of pulmonary hypertension (PH) in infants with isolated giant omphaloceles (GO).
- To compare postnatal morbidities between infants with GO who developed PH and those who did not.
Main Methods:
- Retrospective review of infants with omphalocele treated at the University Hospital of Lille (1996-2021).
- Inclusion criteria: isolated GO involving liver, treated with delayed surgical closure.
- Comparison of prenatal/postnatal data and morbidities between GO infants with and without PH.
Main Results:
- 30% incidence of PH observed in 50 infants with isolated GO.
- Prolonged inflammatory state (CRP > 15 mg/L, platelets > 500 G/L, WBC > 15 G/L for >14 days) was significantly more frequent in infants with PH (73% vs. 21%, p < 0.05).
- No significant difference in late-onset infection rates between groups.
Conclusions:
- A prolonged inflammatory syndrome appears to be a significant contributor to PH development in infants with isolated GO managed with delayed surgical closure.
- Monitoring inflammatory markers may be crucial for early detection and management of PH in this vulnerable population.
Abstract:
Our objective is to determine perinatal factors contributing to the development of pulmonary hypertension (PH) in patients with isolated giant omphaloceles (GO). All cases of omphaloceles that underwent prenatal and postnatal care at the University Hospital of Lille between 1996 and 2021 were reviewed. We included all infants with isolated GO, including at least a part of the liver, who were treated by delayed surgical closure. Prenatal and postnatal data were recorded and correlated with postnatal morbidities. We compared outcomes between a group of infants with GO who developed PH and infants with GO with no PH. We identified 120 infants with omphalocele. Fifty isolated GO cases fulfilled the inclusion criteria of our study. The incidence of PH was 30%. We highlighted a prolonged inflammatory state, defined as a CRP superior to 15 mg/L, platelets higher than 500 G/L, and white blood cells higher than 15 G/l for more than 14 days in patients who developed PH. This event occurred in 73% of patients with PH versus 21% of patients without PH (p < 0.05). Late-onset infection was not different between the two groups. We speculate that prolonged inflammatory syndrome promotes PH in infants with GO treated with delayed surgical closure.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumothorax-II
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

